A study finds that former cancer patients are not more likely to die from COVID than non-cancer patients, if they aren't having active treatment.
Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.
According to a report, more than 340,000 cancer patients could face late diagnosis - due to NHS staff shortages.
Sean Lawler, Associate Professor at Brown University, explains solving the riddle when it comes to the cytomegalovirus virus and the lethal brain tumour, glioblastoma.
Sabine Mai and Aline Rangel-Pozzo from CancerCare Manitoba Research Institute, The University of Manitoba, explore how 3D imaging and quantitative analysis provide key insights into genomic instability.
Professor Giovanni Brandi and Dr Simona Tavolari, explore the link between asbestos exposure and cholangiocarcinoma malignancies
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Study shows L-methylfolate, when administered alongside standard therapy for glioblastomas, changed the DNA process within a patients tumour
An ultrasound can diagnose most prostate cancer cases in men with great accuracy – only missing 3.4% of severe cases.
Lester Litchfield, Data & Science Manager, Volpara Health, explores how to build confidence in the use of AI for mammography clinical practice Artificial Intelligence (AI)...
Analysis of 28 studies has found that the intersection of sexual minority status with ethnicity is associated with lower cancer screenings.
Researchers analysing dietary habits find that those who consume meat five times or less weekly have a lower cancer risk.
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
Chair of Medical Cell BioPhysics Leon WMM Terstappen highlights why the interrogation of the cancer cells at the single cell level is required to truly understand cancer development.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the main focus of non-melanoma skin cancer, including its steadily rising incidence in the UK.
The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.
Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.
An ongoing clinical trial led by the NCI Centre for Cancer Research reveals an experimental form of immunotherapy for metastatic breast cancer.